Shaminie Shanmugaranjan

机构：NHS Blood and Transplant · ORCID：0009-0009-2091-4014

发表论文 7 篇 · 总被引 368 次 · h-index 5

代表论文

• Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19 (2021 · JAMA · 被引 216)
• Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury (2023 · JAMA · 被引 124)
• Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial (2024 · The Lancet Haematology · 被引 14)
• Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis (2024 · Health Technology Assessment · 被引 7)
• UK audit of the management of major bleeding and time taken to deliver blood products (2022 · British Journal of Anaesthesia · 被引 5)
• Influence of surgeon learning on outcomes in new ophthalmic procedures: quantified nationwide evidence in endothelial corneal transplantation (2024 · British Journal of Ophthalmology · 被引 2)